Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2738 - Specialized ambulatory palliative care: (SAPV) 5-year results of a multi-professional care model by HomeCare linker Niederrhein gGmbH (HC) in the Lower Rhine region

Date

10 Sep 2017

Session

Poster display session

Presenters

Ulrich Grabenhorst

Citation

Annals of Oncology (2017) 28 (suppl_5): v497-v501. 10.1093/annonc/mdx382

Authors

U. Grabenhorst

Author affiliations

  • Sapv, HomeCare linker Niederrhein gGmbH, 41751 - Viersen/DE
More

Resources

Abstract 2738

Background

In recent times, German legislation has given terminally ill patients the right to receive SAPV, a multi-professional palliative care model which is aimed at prevention of hospital admission and enabling patients to die at home despite severe symptoms and a high need for palliative care. This new type of care raises the question about the best implementation and impact of SAPV. HC provides SAPV to 560.000 inhabitants of the city of Mönchengladbach and the district of Viersen.

Methods

Data collected during daily care from 2012 to 2016 are summarized and analysed in order to describe the implementation and results of SAPV.

Results

1798 patients were treated in 5 years. The first contact with SAPV was initiated by a GP in 30% of patients and by a specialist in 4.5%; in 26% through a hospital, in 6% by a palliative care unit and in at least 30% by non-medical participants, such as relatives, nursing services, counseling centers etc. 20% of all patients were treated only temporarily by SAPV. 6% were admitted to a hospice, 14% were transferred to regular care after counseling or crisis intervention. Of the remaining patients, only 3.3% had to be hospitalized at the end and 96.7% were able to remain in their chosen home environment. That was at home for 80%, at a relative’s home for 3%, in a nursing home for 14%, and miscellaneous for the remaining 3% of patients. Sonography, thoracic and abdominal paracentesis, patient-controlled analgesia etc. were performed in the patient's home by the SAPV team. Of all 1798 patients, 112 had to be hospitalized; 64 were subsequently retreated with SAPV and 48 were not. The main reasons for hospitalization were palliative interventions due to ileus and urinary retention in the upper tract, radiation of a fracture, psychosocial decompensation of the supporting relatives and confirmation of the palliative concept. The average treatment duration was 19 days, the median was under 10 days. In detail, 112 patients were treated for less than 24 hours, 271 patients for less than 48 hours, 57 patients were treated for more than 90 days and 4 patients for over 200 days.

Conclusions

The wish of patients to die at home and to avoid unnecessary hospitalization can be achieved with this model of specialized care. Further comparative investigations are necessary to identify the optimal implementation and impact of SAPV.

Clinical trial identification

not applicable

Legal entity responsible for the study

Ulrich Grabenhorst

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.